Showing results (51-60 of 237) with videos related to

Sort By:
Pageof 24
Schizophrenia Bulletin Open|August 12, 2026
Oxidative Damage Induced Disruption of Mitochondrial Quality Control Underlying Abnormal Energy Metabolism in Peripheral Leukocytes of Schizophrenia PatientsShuhui Li, Wenli Zhu, Jie Jiang, et al.
Schizophrenia Bulletin Open|August 19, 2026
From Micro Molecular to Functional Levels Through Macro Structures: Mediation of Structural Brain Changes on the Relationship Between Oxidative Stress and Cognition in Early Onset PsychosisMara Villar-Arenzana, Belén Taulero-Escalera, Karina S MacDowell, et al.
Schizophrenia Bulletin Open|September 13, 2026
Subjective Perceptions of Digital Phenotyping Measures of Negative Symptoms Among Individuals At Clinical High Risk for Psychosis and Their RelativesZhixin Zhang, Ada L Hutcheson, Lauren E Arnold, et al.
Schizophrenia Bulletin Open|September 29, 2026
Better Safe Than Sorry? Exploratory Associations Between Fear-Learning Processes and Later Paranoia in Threat-Exposed Adolescents in Standardized Virtual Reality EnvironmentsCansel Inan, Celine Samaey, Kristof Vansteelandt, et al.
Schizophrenia Bulletin Open|May 3, 2021
Mobile RDoC: Using Smartphones to Understand the Relationship Between Auditory Verbal Hallucinations and Need for CareDror Ben-Zeev, Benjamin Buck, Ayesha Chander, et al.
Schizophrenia Bulletin Open|August 27, 2025
Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia ProgramJean Addington, Amy Shalev, Lu Liu, et al.
Schizophrenia Bulletin Open|December 13, 2021
What is the Best Latent Structure of Negative Symptoms in Schizophrenia? A Systematic ReviewBernardo Haguiara, Gabriela Koga, Elton Diniz, et al.
Schizophrenia Bulletin Open|December 13, 2021
Investigating Patient Acceptability of Stratified Medicine for Schizophrenia: A Mixed Methods StudySagar Jilka, Clarissa Mary Odoi, Sazan Meran, et al.
Schizophrenia Bulletin Open|December 13, 2021
Inherited L1 Retrotransposon Insertions Associated With Risk for Schizophrenia and Bipolar DisorderBenjamin C Reiner, Glenn A Doyle, Andrew E Weller, et al.
Schizophrenia Bulletin Open|December 13, 2021
The Impact of Aberrant Data Variability on Drug-Placebo Separation and Drug/Placebo Response in an Acute Schizophrenia Clinical TrialAlan Kott, Stephen Brannan, Xingmei Wang, et al.
Pageof 24